February 2015 FDA Recall Drug by Mylan Institutional Llc
D-0412-2015 - Correct Labeled Product Mispack

This Class III drug recall was voluntarily initiated by Mylan Institutional Llc on February 11, 2015 for the product Drug. The FDA reported the reason for recall as correct labeled product mispack. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0412-2015

Reason for Recall
Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL
Initiated
02-11-2015
Reported
03-25-2015
Quantity
936 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Institutional LLC
DOXOrubicin Hydrochloride Injection, USP, 200 mg/100 mL (2 mg/mL), For IV Use Only, Sterile, ISOTONIC SOLUTION, Caution: Cytotoxic Agent, 100 mL Multi-Dose Vial, Rx Only, Manufactured By: Onco Therapies Limited, Bangalore, 560105, INDIA, Distributed By: Amneal-Agila, LLC, Glasgow, KY, 42141, NDC 53150-317-01.

Batch or Lot Expiration Information

Lot# Lot Number: 7801009; Exp: Apr-2015